The Hemophilia Inhibitor Prevention Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a multi-center randomized phase III clinical trial, the Inhibitor Prevention Trial, in which Eloctate will be compared with Emicizumab, using adaptive design, to prevent inhibitors in patients with severe hemophilia A.
Epistemonikos ID: e6e271889716238e109e30dccae1c816a11a88c2
First added on: May 07, 2024